Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scaffidi

Showing results (411-420 of 420) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 420 results.
Blood Cancer Journal|March 15, 2018
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasmsValerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
Leukemia|November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
American Journal of Hematology|December 10, 2019
Second cancers in MPN: Survival analysis from an international studyMonia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
Blood|December 27, 2019
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML studySimona Soverini, Luana Bavaro, Caterina De Benedittis, et al.
Oncotarget|September 1, 2016
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcomeAlessandra Iurlo, Alessandro Nobili, Roberto Latagliata, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|May 6, 2022
Simple and statistically sound recommendations for analysing physical theoriesShehu S AbdusSalam, Fruzsina J Agocs, Benjamin C Allanach, et al.
Nature|February 26, 2025
Hardware-efficient quantum error correction via concatenated bosonic qubitsHarald Putterman, Kyungjoo Noh, Connor T Hann, et al.
Pageof 42

Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
Blood Cancer Journal|March 15, 2018
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasmsValerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, et al.
Blood|December 24, 2019
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control studyValerio De Stefano, Arianna Ghirardi, Arianna Masciulli, et al.
Leukemia|November 20, 2019
Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryHanneke C Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, et al.
American Journal of Hematology|December 10, 2019
Second cancers in MPN: Survival analysis from an international studyMonia Marchetti, Arianna Ghirardi, Arianna Masciulli, et al.
Theranostics|January 4, 2021
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosisHanneke C Kluin-Nelemans, Mohamad Jawhar, Andreas Reiter, et al.
Blood|December 27, 2019
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML studySimona Soverini, Luana Bavaro, Caterina De Benedittis, et al.
Oncotarget|September 1, 2016
Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcomeAlessandra Iurlo, Alessandro Nobili, Roberto Latagliata, et al.
Leukemia|September 21, 2021
Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosisRoberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|May 6, 2022
Simple and statistically sound recommendations for analysing physical theoriesShehu S AbdusSalam, Fruzsina J Agocs, Benjamin C Allanach, et al.
Nature|February 26, 2025
Hardware-efficient quantum error correction via concatenated bosonic qubitsHarald Putterman, Kyungjoo Noh, Connor T Hann, et al.
Pageof 42